Patents Represented by Attorney, Agent or Law Firm Tara Seshadri
  • Medical treatment
    Patent number: 6617360
    Abstract: A compound of formula I or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for reducing Insulin resistance in humans in whom Impaired Glucose Tolerance and Non-Insulin Dependent Diabetes Mellitus have not presented.
    Type: Grant
    Filed: October 30, 2000
    Date of Patent: September 9, 2003
    Assignee: Knoll Aktiengesellschaft
    Inventors: Clifford James Bailey, Robert Brian Jones, Helen Christine Jackson
  • Therapeutic agent comprising (+)-sibutramine
    Patent number: 6552087
    Abstract: The use of (+)-sibutramine in the treatment of depression, obesity, Parkinson's disease, cerebral function disorders and diabetes is described.
    Type: Grant
    Filed: March 17, 2000
    Date of Patent: April 22, 2003
    Assignee: Abbott GmbH & Co. KG
    Inventors: Sharon C. Cheetham, David John Heal